Kaeley, Gurjit S. http://orcid.org/0000-0003-1335-3131
Kaler, Jaspreet K. http://orcid.org/0000-0002-3157-5689
Article History
First Online: 27 July 2020
Compliance with Ethical Standards
:
: No funding was received to support the writing of this manuscript.
: Gurjit S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation and Janssen, as well as research grants from Abbvie, Gilead, Janssen, and Pfizer. Jaspreet K. Kaler has no conflicts of interest to declare.